Mercury Laboratories Ltd.
Fundamentals
- Market cap
- ₹91.61 cr
- P/E
- 19.42×
- ROE
- 5.87%
- Debt / equity
- 0.08
- Div yield
- 0.46%
- 52-week range
- 620.55 — 976.00
The timeline — 2 notes on Mercury Laboratories Ltd.
May 2026
- 29 May 26 · 4:22 PM IST Brief Brief · Earnings · Micro cap
Mercury Laboratories profit jumps 54% as revenue stays flat
The pharma firm reported a net profit of ₹4.83 crore for FY26, prompting a 35% dividend recommendation for shareholders.
- 29 May 26 · 4:17 PM IST Brief Brief · Earnings · Micro cap
Mercury Laboratories lifts annual profit by 59% to ₹4.93 crore
The pharmaceutical firm reported an annual net profit of ₹4.93 crore, up from ₹3.10 crore in the prior year, alongside a 35% dividend recommendation.